NinePointTwo Capital LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 236 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
NinePointTwo Capital LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$120
-16.1%
17,1740.0%0.05%
-14.8%
Q1 2023$143
-27.4%
17,1740.0%0.05%
-34.1%
Q4 2022$19717,1740.08%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
VHCP Management II, LLC 6,071,142$38,430,00018.43%
RTW INVESTMENTS, LP 4,078,895$25,819,0009.72%
VHCP Management, LLC 1,155,104$7,312,0007.86%
RA Capital Management 2,989,795$18,925,0002.68%
DLD Asset Management, LP 1,258,700$7,967,0002.61%
Avoro Capital Advisors LLC 1,631,502$10,327,0002.09%
Ghost Tree Capital, LLC 1,150,000$7,280,0001.75%
GREAT POINT PARTNERS LLC 725,000$4,589,0000.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,237,734$20,495,0000.84%
Baker Brothers Advisors 10,963,944$69,402,0000.68%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders